Compound Detail
CHEMBL434200
TERTATOLOL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL434200 |
| Name | TERTATOLOL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | HTWFXPCUFWKXOP-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
1
Targets
4
Activities
1
Assay Types
0
PK Parameters
20
Publications
6
Known Names
1
Indications
Molecular Properties
295.4
MW (Da)
2.85
ALogP
4
HBA
2
HBD
41.5
PSA (Ų)
0.88
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Indications
Cardiovascular Diseases
ATC Classification
C07AA16
tertatolol
Level 1: CARDIOVASCULAR SYSTEM
Level 2: BETA BLOCKING AGENTS
Activity Summary
Ki 4 meas. best 8.11
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 8.11 | 7.75 | 7.7 | 4 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Ki | = | 7.71 | nM | 8.11 | The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A r... | - |
| 5-hydroxytryptamine receptor 1A | Ki | = | 18.2 | nM | 7.74 | Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A recept... | - |
| 5-hydroxytryptamine receptor 1A | Ki | = | 18.62 | nM | 7.73 | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) r... | 8568799 |
| 5-hydroxytryptamine receptor 1A | Ki | = | 37.6 | nM | 7.42 | The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A r... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.1016/S0960-894X(97)00046-2 | ADMET | 4 |
| - | 10.1016/S0960-894X(01)81009-X | 5-hydroxytryptamine receptor 1A | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Vascular endothelial growth factor receptor 2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent serotonin transporter | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent noradrenaline transporter | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Acetylcholinesterase | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 1 |
| 8568799 | 10.1021/jm950410b | 5-hydroxytryptamine receptor 1A | 1 |
| 2903243 | 10.1021/jm00119a004 | Beta-2 adrenergic receptor | 1 |
| 2903243 | 10.1021/jm00119a004 | Beta-1 adrenergic receptor | 1 |
| 2903243 | 10.1021/jm00119a004 | Adrenergic receptor beta | 1 |
Data from ChEMBL 36 via Core Engine